Cargando…
Serum Helicobacter pylori FliD antibody and the risk of gastric cancer
FliD and CagA are important virulence factors of H. pylori. We aimed to evaluate the screening values of FliD and CagA for gastric cancer (GC). Serum samples were obtained from 232 cases and 266 controls in a case-control study. Unconditional multivariate logistic regression with odds ratios (ORs) a...
Autores principales: | Li, Hailin, Zhang, Bing, Hu, Xiaomeng, Dong, Yingzi, Fan, Qing, Guo, Fang, Ren, Xiyun, Zhou, Haibo, Tian, Wenjing, Zhao, Yashuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008368/ https://www.ncbi.nlm.nih.gov/pubmed/26968951 http://dx.doi.org/10.18632/oncotarget.7981 |
Ejemplares similares
-
Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer
por: Liu, Jingjing, et al.
Publicado: (2014) -
The role of the FliD C-terminal domain in pentamer formation and interaction with FliT
por: Kim, Hee Jung, et al.
Publicado: (2017) -
Prophylactic Activity of Orally Administered FliD-Reactive Monoclonal SIgA Against Campylobacter Infection
por: Perruzza, Lisa, et al.
Publicado: (2020) -
Evaluation of flagellum-related proteins FliD and FspA as subunit vaccines against Campylobacter jejuni colonisation in chickens
por: Chintoan-Uta, C., et al.
Publicado: (2016) -
Association between Gastric Cancer Risk and Serum Helicobacter pylori Antibody Titers
por: Shuto, Mitsutaka, et al.
Publicado: (2017)